Q3 2020 Review +12%, + 39% YTD

A very quiet quarter for me. I have made very few changes. This is being written a few days before the end of September so figures may differ slightly, but baring an unexpected disaster / triumph this is roughly where I will be…

• Got rid of EOS Russia – no real reason – it just hadn’t performed well and a realized loss is good to manage my CGT position. I may well re-enter.
• Sold some Beximco on a ridiculous spike buying some of it back lower down – I will refill my position again lower down.
• Sold a bit of CMC Markets – as my position was a bit big and wanted to buy other things.
• Sold half my SERE on a dip – this was an unwise panicking out on something of a headfake. Could be summer ‘silly season’ low volume move. I am noticing more stocks than usual falling with no reason.
• Sold half GPSS to take some profit.
• Most impactful change was buying 4D Pharma in the placement. This has done brilliantly for me – more later.

My portfolio is below:

Advertisement

2018 Performance / Portfolio Review -13%, could be worse

As 2018 is almost over I think it’s time to review the portfolio and performance.

Overall result is -13%. Somewhat depends on calculations –  I use broker day end values.  so more or less… This can be compared to -9.7% FTSE all share (total return), far below my 30% target for the year.  Many ideas havent worked this year so what has saved me is profit which was really from 2017 and rolled over the year end in the calculation – particularly Tejoori.

Long term performance has been strong – still 7X up over the last 10 years – long term chart below:

$DDDD 4D Pharma – an experiment

A couple of weeks ago I bought a very small (just over 1%) (probably too small) portfolio weight in 4D Pharma at 247p per share.

This is very much an experiment for me – its the first pharma stock I have ever bought in my 17 years investing.

DDDD are a company involved in developing remedies related to bio-theraputics.  This is using the body’s own bacteria / product of that bacteria to heal.  They are initially focused on gastrointestinal issues.